Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography

Archives of Cardiovascular Diseases

Volumn 104, Issue 3, 2011, Pages 147-154

  Souteyrand, Geraud ^a,b,c   Levesque, Sebastien ^a   Ouchchane, Lemlih ^b   Sarry, Laurent ^b   Eschalier, Romain ^a   Lusson, Jean René ^a,b   Motreff, Pascal ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Neointimal hyperplasia; Optical coherence tomography; Zotarolimus eluting stent

Indexed keywords

ZOTAROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DRUG ELUTING STENT; FEMALE; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; NEOINTIMAL HYPERPLASIA; OPTICAL COHERENCE TOMOGRAPHY; PATIENT MONITORING;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG THERAPY, COMBINATION; DRUG-ELUTING STENTS; FEMALE; FRANCE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUNICA INTIMA;

EID: 79954633397     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2010.12.004     Document Type: Article

References (25)

1. J. Fajadet, W. Wijns, and G.J. Laarman Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine- encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial Circulation 114 2006 798 806 (Pubitemid 44268230)
2. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323 (Pubitemid 37186209)
3. G.W. Stone, S.G. Ellis, and D.A. Cox One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial Circulation 109 2004 1942 1947 (Pubitemid 38544483)
4. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
5. M.N. Babapulle, L. Joseph, and P. Belisle A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591 (Pubitemid 39094175)
6. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130 (Pubitemid 40617065)
7. P. Wenaweser, J. Daemen, and M. Zwahlen Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study J Am Coll Cardiol 52 2008 1134 1140
8. D.R. Holmes Jr., D.J. Kereiakes, and W.K. Laskey Thrombosis and drug-eluting stents: an objective appraisal J Am Coll Cardiol 50 2007 109 118 (Pubitemid 47007739)
9. M. Awata, J. Kotani, and M. Uematsu Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents Circulation 116 2007 910 916 (Pubitemid 47300915)
10. A.V. Finn, G. Nakazawa, and M. Joner Vascular responses to drug-eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510 (Pubitemid 46986103)
11. A.V. Finn, M. Joner, and G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441 (Pubitemid 46717966)
12. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202 (Pubitemid 43929240)
13. B.X. Chen, F.Y. Ma, and W. Luo Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography Heart 94 2008 566 570 (Pubitemid 351580126)
14. D. Matsumoto, J. Shite, and T. Shinke Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 2007 961 967 (Pubitemid 47343895)
15. M. Takano, S. Inami, and I.K. Jang Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation Am J Cardiol 99 2007 1033 1038 (Pubitemid 46560470)
16. M. Takano, M. Yamamoto, and S. Inami Long-term follow-up evaluation after sirolimus-eluting stent implantation by optical coherence tomography: do uncovered struts persist? J Am Coll Cardiol 51 2008 968 969 (Pubitemid 351282461)
17. S.J. Pocock, A.J. Lansky, and R. Mehran Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials J Am Coll Cardiol 51 2008 23 32
18. J.S. Kim, I.K. Jang, and T.H. Kim Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents Heart 95 2009 1907 1912
19. P. Motreff, G. Souteyrand, and S. Levesque Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation Arch Cardiovasc Dis 102 2009 617 624
20. Guagliumi G, Sirbu V, Suzuki N, et al. Prospective, randomized, controlled study using optical coherence tomography to evaluate strut coverage of Sirolimus-, Paclitaxel- and Zotarolimus-Eluting coronary stents in long lesions requiring overlapping (ODESSA-OCT for DES safety). Am J Cardiol 200;102. (abstract).
21. R. Kornovski The long-term results of the "Endeavor" stent Catheter Cardiovasc Interv 74 2009 996 999
22. M. Takano, M. Yamamoto, and Y. Xie Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy Heart 93 2007 1533 1536 (Pubitemid 350205543)
23. K. Sano, G.S. Mintz, and S.G. Carlier Volumetric intravascular ultrasound assessment of neointimal hyperplasia and non-uniform stent strut distribution in sirolimus-eluting stent restenosis Am J Cardiol 98 2006 1559 1562 (Pubitemid 44827960)
24. H. Takebayashi, G.S. Mintz, and S.G. Carlier Non-uniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation Circulation 110 2004 3430 3434 (Pubitemid 39602221)
25. H. Kaneda, J. Ako, and M. Terashima Distribution pattern of neointimal hyperplasia following sirolimus-eluting stent implantation assessed by 3-dimensional intravascular ultrasound Int J Cardiol 135 2009 243 245